113 related articles for article (PubMed ID: 10346918)
1. C-1027-induced alterations in Epstein-Barr viral DNA replication in latently infected cultured human Raji cells: relationship to DNA damage.
McHugh MM; Beerman TA
Biochemistry; 1999 May; 38(21):6962-70. PubMed ID: 10346918
[TBL] [Abstract][Full Text] [Related]
2. DNA-damaging enediyne C-1027 inhibits initiation of intracellular SV40 DNA replication in trans.
McHugh MM; Beerman TA; Burhans WC
Biochemistry; 1997 Feb; 36(5):1003-9. PubMed ID: 9033389
[TBL] [Abstract][Full Text] [Related]
3. Damage induced in episomal EBV DNA in Raji cells by antitumor drugs as measured by pulsed field gel electrophoresis.
Johnson PG; Beerman TA
Anal Biochem; 1994 Jul; 220(1):103-14. PubMed ID: 7526729
[TBL] [Abstract][Full Text] [Related]
4. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
5. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
6. The cellular response to DNA damage induced by the enediynes C-1027 and neocarzinostatin includes hyperphosphorylation and increased nuclear retention of replication protein a (RPA) and trans inhibition of DNA replication.
McHugh MM; Yin X; Kuo SR; Liu JS; Melendy T; Beerman TA
Biochemistry; 2001 Apr; 40(15):4792-9. PubMed ID: 11294647
[TBL] [Abstract][Full Text] [Related]
7. Cocaine potentiates the switch between latency and replication of Epstein-Barr virus in Raji cells.
Di Francesco P; Lisi A; Rieti S; Manni V; Grimaldi S; Garaci E
Biochem Biophys Res Commun; 1999 Oct; 264(1):33-6. PubMed ID: 10527836
[TBL] [Abstract][Full Text] [Related]
8. Bizelesin, a bifunctional cyclopropylpyrroloindole alkylating agent, inhibits simian virus 40 replication in trans by induction of an inhibitor.
McHugh MM; Kuo SR; Walsh-O'Beirne MH; Liu JS; Melendy T; Beerman TA
Biochemistry; 1999 Aug; 38(35):11508-15. PubMed ID: 10471303
[TBL] [Abstract][Full Text] [Related]
9. Interactions of Epstein-Barr virus origins of replication with nuclear matrix in the latent and in the lytic phases of viral infection.
Mattia E; Ceridono M; Chichiarelli S; D'Erme M
Virology; 1999 Sep; 262(1):9-17. PubMed ID: 10489336
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.
Lu CC; Jeng YY; Tsai CH; Liu MY; Yeh SW; Hsu TY; Chen MR
Virology; 2006 Feb; 345(2):358-72. PubMed ID: 16298410
[TBL] [Abstract][Full Text] [Related]
11. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
12. Visualization of DNA replication on individual Epstein-Barr virus episomes.
Norio P; Schildkraut CL
Science; 2001 Dec; 294(5550):2361-4. PubMed ID: 11743204
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R
Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines.
Jiang R; Kanamori M; Satoh Y; Fukuda M; Ikuta K; Murakami M; Sairenji T
J Med Virol; 2003 Jun; 70(2):244-52. PubMed ID: 12696111
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
18. Episomal replication timing of gamma-herpesviruses in latently infected cells.
Vogel B; Full F; Biesinger B; Linden C; Alberter B; Ensser A
Virology; 2010 May; 400(2):207-14. PubMed ID: 20172574
[TBL] [Abstract][Full Text] [Related]
19. Architecture of replication compartments formed during Epstein-Barr virus lytic replication.
Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Shirata N; Tsurumi T
J Virol; 2005 Mar; 79(6):3409-18. PubMed ID: 15731235
[TBL] [Abstract][Full Text] [Related]
20. Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells.
Liu SF; Wang H; Li ZJ; Deng XY; Xiang H; Tao YG; Li W; Tang M; Cao Y
Eur J Pharmacol; 2008 Jul; 589(1-3):8-13. PubMed ID: 18571159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
